Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.18 USD -4.21% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Supernus Pharmaceuticals Inc
Other Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Other Equity
$78k
CAGR 3-Years
-74%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Other Equity
-$12.5B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
-9%
Bristol-Myers Squibb Co
NYSE:BMY
Other Equity
-$1.5B
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
6%
Pfizer Inc
NYSE:PFE
Other Equity
-$7.8B
CAGR 3-Years
-12%
CAGR 5-Years
8%
CAGR 10-Years
-9%
Merck & Co Inc
NYSE:MRK
Other Equity
-$5.4B
CAGR 3-Years
-5%
CAGR 5-Years
0%
CAGR 10-Years
-6%
Eli Lilly and Co
NYSE:LLY
Other Equity
-$4.3B
CAGR 3-Years
12%
CAGR 5-Years
6%
CAGR 10-Years
-5%

See Also

What is Supernus Pharmaceuticals Inc's Other Equity?
Other Equity
78k USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's Other Equity amounts to 78k USD.

What is Supernus Pharmaceuticals Inc's Other Equity growth rate?
Other Equity CAGR 5Y
-60%

The average annual Other Equity growth rates for Supernus Pharmaceuticals Inc have been -74% over the past three years , -60% over the past five years .

Back to Top